Tag: Treatment
-
The changing landscape of neurological conditions across all ages at Zydus Hospital, Vadodara
AHMEDABAD, India, Oct. 23, 2026 /PRNewswire/ — More than three billion people, over 40 per cent of the world’s population, are affected by neurological conditions, according to the World Health Organization. Neurological disorders affect the central nervous system or the peripheral nervous system a…
-
Therakos Receives MDR Approval in Europe for Treating Immune-Related Adverse Events in Patients with Inadequate Response to Corticosteroids
DUBLIN, Oct. 21, 2026 /PRNewswire/ — Therakos Development Limited, a global pioneer in immunomodulatory therapy delivered at the bedside through extracorporeal photopheresis (ECP), announced today that its THERAKOS™ CELLEX™ Photopheresis System has received certification under the EU MDR for an exp…
-
Pope Leo XIV's Lung Cancer Diagnosis Puts Spotlight on Hope and Advances in Treatment
IASLC highlights global collaboration, advancing lung cancer care and bringing new hope to patients and families.DENVER, Oct. 15, 2026 /PRNewswire/ — Pope Leo XIV’s diagnosis of lung adenocarcinoma has brought global attention to a disease that affects millions of individuals and families across ev…
-
Opella: New study demonstrates successful cough treatment extends beyond symptom relief
PARIS, Oct. 15, 2026 /PRNewswire/ — A new real-world study from Opella, the maker of Mucosolvan and Bisolvon, provides pharmacists with compelling evidence that the success of a cough treatment should be measured by its impact on a patient’s overall well-being, alongside traditional symptomatic rel…
-
ArkBio Announces FDA Clearance to Initiate Phase II Trial of AK0406 for Influenza Prevention
SHANGHAI, Oct. 13, 2026 /PRNewswire/ — Shanghai Ark Biopharmaceutical Co., Ltd. (“ArkBio”) today announced that the U.S. Food and Drug Administration (FDA) has granted its investigational new drug (IND) application for AK0406, a long-acting antiviral drug-Fc conjugate (AFC), enabling the company to…
-
NCCN Highlights Collaborations to Improve Global Cancer Outcomes During Meetings in North America and Asia
National Comprehensive Cancer Network participates in annual conferences for the International Gynecologic Cancer Society and Philippine Society of Medical Oncology in efforts to standardize cancer treatment recommendations.MONTREAL and MANILA, Philippines, Oct. 8, 2026 /PRNewswire/ — The National …
-
From diagnosis to treatment, ZEISS introduces innovations across ZEISS Retina Workflow at EURETINA 2026
ZEISS Medical Technology advances its ZEISS Retina Workflow with digital and surgical enhancements, and new imaging technologies, including:Diagnostics: ZEISS expands its retinal imaging portfolio with the new ZEISS ALTA DUO 300, combining OCT and fundus imaging in a single device. Visualization: Ne…
-
NCCN Models How to Tailor Cancer Care for Different Regions During 2026 World Cancer Congress
National Cancer Control Plans can and should include regionally appropriate guidelines according to abstracts presented by the National Comprehensive Cancer Network during global event hosted by the Union of International Cancer Control.PLYMOUTH MEETING, Pa. and HONG KONG, Sept. 24, 2026 /PRNewswire…
-
Morphy Richards Brings Fresh Vision to Its 90-Year Legacy at IFA Berlin 2026
BERLIN, Sept. 23, 2026 /PRNewswire/ — Morphy Richards, the British small appliance brand celebrating its 90th anniversary, concluded a successful appearance at IFA Berlin 2026 with innovations across Kitchen Solutions and Air Treatment. At IFA, the brand presented its Smart Ideas philosophy: ideas …
-
HCG Cancer Hospital Mumbai Treats 125+ Prostate Cancer Patients Without Surgery or Hospital Stay
Advanced SBRT offers precise prostate cancer treatment in just five sessions, powered by Versa HD and CyberKnife Mumbai’s first and only platformMUMBAI, India, Sept. 22, 2026 /PRNewswire/ — Prostate cancer treatment does not always require surgery or prolonged hospitalisation. At HCG Cancer Hospita…
Latest News
About the Author
Your reliable go-to for precise and up-to-date information!
We are dedicated to accuracy, impartiality, and providing news as it unfolds, earning the trust of a wide audience. Keep up with real-time updates on the latest events and trends.